BIOSTAR PHARM-B (02563) announced that the Grand Court of the Cayman Islands (Financial Services Division) ruled on December 3, 2025, approving the company's application to appoint a receiver for the sub-fund LFM Stable Income Fund SP. The court recognized US-Biostar as a creditor under the terms of the subscription letter. The company's legal counsel has communicated with the appointed receiver, who will initiate liquidation petitions and receivership procedures for LFM Fund in accordance with Cayman Islands law. On December 10, 2025, the company contacted the receiver to advance the receivership process.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments